Skip to main content
SpringerLink
Log in

Cancer Survivorship in Women 65 Years and Older

  • Chapter
  • First Online:
Challenges in Older Women’s Health

  • 419 Accesses

Abstract

Cancer survivors are defined as any person with a history of cancer, from the time of diagnosis through the remainder of life. The number of cancer survivors in the United States exceeds 16 million. Most survivors will live 5 or more years after diagnosis, many with chronic needs related to cancer diagnosis as well as a higher rate of comorbid chronic health conditions. Common long-term adverse effects of cancer and cancer treatment including pain, neuropathy, and depressionare likely to be encountered and treated by non oncology providers . Common preventative health interventions such as screening for other cancers and counseling regarding healthy diet, exercise, reducing alcohol, and tobacco cessation can reduce the risk of cancer recurrence, death, and all-cause mortality in cancer survivors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Cancer Treatment and Survivorship Facts & Figures 2019–2021. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/cancer-treatment-and-survivorship-facts-and-figures/cancer-treatment-and-survivorship-facts-and-figures-2019-2021.pdf. Accessed 12 Dec 2019.

  2. Hewitt ME, et al. From cancer patient to cancer survivor: lost in transition. Washington, DC: The National Academies Press; 2006. xxv, 506 p.

    Google Scholar 

  3. Nekhlyudov L, Omalley DM, Hudson SV. Integrating primary care providers in the care of cancer survivors: gaps in evidence and future opportunities. Lancet Oncol. 2017. https://doi.org/10.1016/s1470-2045(16)30570-8.

  4. Miller KD, Noqueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69(5):363–85.

    Article  Google Scholar 

  5. Bluethmann SM, Mariotto AB, Rowland JH. Anticipating the “silver tsunami”: prevalence trajectories and comorbidity burden among older cancer survivors in the United States. Cancer Epidemiol Biomark Prev. 2016;25:1029–36.

    Article  Google Scholar 

  6. Yabroff KR, Lawrence WF, Clauser S, Davis WW, Brown ML. Burden of illness in Cancer survivors: findings from a population-based National Sample. J Natl Cancer Inst. 2004;96:1322–30.

    Article  Google Scholar 

  7. Snyder CF, Frick KD, Herbert RJ, Blackford AL, Neville BA, Lemke KW, Carducci MA, Wolff AC, Earle CC. Comorbid condition care quality in cancer survivors: role of primary care and specialty providers and care coordination. J Cancer Surviv. 2015;9:641–9.

    Article  Google Scholar 

  8. Donohue S, et al. Cancer survivorship care plan utilization and impact on clinical decision-making at point-of-care visits with primary care: results from an engineering, primary care, and oncology collaborative for survivorship health. J Cancer Educ. 2019;34(2):252–8.

    Article  Google Scholar 

  9. Petterson SM, Liaw WR, Phillips RL, Rabin DL, Meyers DS, Bazemore AW. Projecting US primary care physician workforce needs: 2010-2025. Ann Fam Med. 2012;10:503–9.

    Article  Google Scholar 

  10. Shulman LN, Jacobs LA, Greenfield S, et al. Cancer care and Cancer survivorship Care in the United States: will we be able to Care for these Patients in the future? J Oncol Pract. 2009;5:119–23.

    Article  Google Scholar 

  11. Moor JSD, Mariotto AB, Parry C, Alfano CM, Padgett L, Kent EE, Forsythe L, Scoppa S, Hachey M, Rowland JH. Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care. Cancer Epidemiol Biomark Prev. 2013;22:561–70.

    Article  Google Scholar 

  12. SEER Cancer Statistics Review, 1975–2016 [Internet]. SEER. [cited 2019 Dec 12]. Available from: https://seer.cancer.gov/csr/1975_2016/

  13. Rock CL, Doyle C, Demark-Wahnefried W, et al. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin. 2012;62:275–6.

    Article  Google Scholar 

  14. Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahnefried W, Dizon D, et al. Survivorship: immunizations and prevention of infections, version 2.2014. J Natl Compr Cancer Netw. 2014;12(8):1098–111.

    Article  Google Scholar 

  15. John GM, Hershman DL, Falci L, Shi Z, Tsai W-Y, Greenlee H. Complementary and alternative medicine use among US cancer survivors. J Cancer Surviv. 2016;10:850–64.

    Article  Google Scholar 

  16. Armes J, Crowe M, Colbourne L, Morgan H, Murrells T, Oakley C, Palmer N, Ream E, Young A, Richardson A. Patients supportive care needs beyond the end of cancer treatment: a prospective, longitudinal survey. J Clin Oncol. 2009;27:6172–9.

    Article  Google Scholar 

  17. Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari S, Ozakinci G. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv. 2013;7:300–22.

    Article  Google Scholar 

  18. Butow P, Sharpe L, Thewes B, Turner J, Gilchrist J, Beith J. Fear of cancer recurrence: a practical guide for clinicians. Oncology (Williston Park). 2018;32:32–8.

    Google Scholar 

  19. Yi JC, Syrjala KL. Anxiety and depression in cancer survivors. Med Clin N Am. 2017;101:1099–113.

    Article  Google Scholar 

  20. Bower JE, Bak K, Berger A, et al. Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical Oncology Clinical Practice Guideline Adaptation. J Clin Oncol. 2014;32:1840–50.

    Article  Google Scholar 

  21. Janelsins MC, Heckler CE, Peppone LJ, et al. Cognitive complaints in survivors of breast Cancer after chemotherapy compared with age-matched controls: an analysis from a nationwide, multicenter, prospective longitudinal study. J Clin Oncol. 2017;35:506–14.

    Article  Google Scholar 

  22. Falk SJ, Dizon DS. Sexual dysfunction in women with cancer. Fertil Steril. 2013;100:916–21.

    Article  Google Scholar 

  23. Morris L, Do V, Chard J, Brand A. Radiation-induced vaginal stenosis: current perspectives. Int J Women’s Health. 2017;9:273–9.

    Article  Google Scholar 

  24. Baumgart J, Nilsson K, Evers AS, Kallak TK, Poromaa IS. Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer. Menopause. 2013;20:162–8.

    Article  Google Scholar 

  25. Guy GP Jr, Ekwueme D, Yabroff K, Dowling E, Li C, Rodriguez J, Moor JD, Virgo K. The economic burden of cancer survivorship among adults in the United States. Value Health. 2013. https://doi.org/10.1016/j.jval.2013.03.666.

  26. Bregendahl S, Emmertsen KJ, Lous J, Laurberg S. Bowel dysfunction after low anterior resection with and without neoadjuvant therapy for rectal cancer: a population-based cross-sectional study. Color Dis. 2013. https://doi.org/10.1111/codi.12244.

  27. Emmertsen KJ, Laurberg S. Impact of bowel dysfunction on quality of life after sphincter-preserving resection for rectal cancer. Br J Surg. 2013;100:1377–87.

    Article  CAS  Google Scholar 

  28. Krouse RS, Herrinton LJ, Grant M, et al. Health-related quality of life among long-term rectal cancer survivors with an ostomy: manifestations by sex. J Clin Oncol. 2009;27:4664–70.

    Article  Google Scholar 

  29. Bekaii-Saab T, El-Rayes BF, Pawlik TM. Handbook of gastrointestinal cancers: evidence-based treatment and multidisciplinary patient care. New York: Springer Publishing Company; 2020.

    Google Scholar 

  30. Mols F, Beijers T, Vreugdenhil G, Poll-Franse LVD. Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review. Support Care Cancer. 2014;22:2261–9.

    Article  Google Scholar 

  31. Gillespie LD, Robertson MC, Gillespie WJ, Sherrington C, Gates S, Clemson LM, Lamb SE. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev. 2012. https://doi.org/10.1002/14651858.cd007146.pub3.

  32. Hershman DL, Lacchetti C, Dworkin RH, et al. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2014;32:1941–67.

    Article  CAS  Google Scholar 

  33. Yusef SW, et al. Radiation-induced heart disease: a clinical update. Cardiol Res Pract. 2011;2011:317659.

    Google Scholar 

  34. Li K, Giustini D, Seely D. A systematic review of acupuncture for chemotherapy-induced peripheral neuropathy. Curr Oncol. 2019. https://doi.org/10.3747/co.26.4261.

  35. Armenian SH, Lacchetti C, Lenihan D. Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline Summary. J Oncol Pract. 2017;13(4):270–5.

    Article  Google Scholar 

  36. Burstein HJ, Lacchetti C, Anderson H, et al. Adjuvant endocrine therapy for women with hormone receptor–positive breast cancer: ASCO clinical practice guideline focused update. J Clin Oncol. 2019;37:423–38.

    Article  CAS  Google Scholar 

  37. Henry NL, Unger JM, Schott AF, et al. Randomized, multicenter, placebo-controlled clinical trial of duloxetine versus placebo for aromatase inhibitor–associated arthralgias in early-stage breast cancer: SWOG S1202. J Clin Oncol. 2018;36:326–32.

    Article  CAS  Google Scholar 

  38. Hadji P, Aapro MS, Body J-J, et al. Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG. J Bone Oncol. 2017;7:1–12.

    Article  Google Scholar 

  39. Matthews A, Stanway S, Farmer RE, Strongman H, Thomas S, Lyon AR, Smeeth L, Bhaskaran K. Long term adjuvant endocrine therapy and risk of cardiovascular disease in female breast cancer survivors: systematic review. BMJ. 2018. https://doi.org/10.1136/bmj.k3845.

  40. Practice Bulletin No. 126: management of gynecologic issues in women with breast cancer. Obstet Gynecol. 2012;119:666–82.

    Google Scholar 

  41. Donneyong MM, Bykov K, Bosco-Levy P, Dong Y-H, Levin R, Gagne JJ. Risk of mortality with concomitant use of tamoxifen and selective serotonin reuptake inhibitors: multi-database cohort study. BMJ. 2016;354:i5014.

    Article  Google Scholar 

  42. Salloum RG, Hornbrook MC, Fishman PA, Ritzwoller DP, Rossetti MCO, Lafata JE. Adherence to surveillance care guidelines after breast and colorectal cancer treatment with curative intent. Cancer. 2012;118:5644–51.

    Article  Google Scholar 

  43. Potosky AL, Han PKJ, Rowland J, Klabunde CN, Smith T, Aziz N, Earle C, Ayanian JZ, Ganz PA, Stefanek M. Differences between primary care physicians’ and oncologists’ knowledge, attitudes and practices regarding the care of cancer survivors. J Gen Intern Med. 2011;26:1403–10.

    Article  Google Scholar 

  44. Yang EJ, Lim J-Y, Rah UW, Kim YB. Effect of a pelvic floor muscle training program on gynecologic cancer survivors with pelvic floor dysfunction: a randomized controlled trial. Gynecol Oncol. 2012;125:705–11.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of General Internal Medicine, Department of Internal Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA

    James E. Haine

  2. Department of Medicine, University of Wisconsin Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA

    Noelle K. LoConte

  3. Division of Hematology, Oncology and Palliative Care, Department of Medicine, University of Wisconsin Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA

    Amye J. Tevaarwerk

Authors
  1. James E. Haine
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Noelle K. LoConte
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Amye J. Tevaarwerk
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to James E. Haine .

Editor information

Editors and Affiliations

  1. Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, University of Wisconsin, School of Medicine and Public Health, Madison, WI, USA

    Heidi W. Brown

  2. Division of Academic Specialists in Obstetrics and Gynecology, Department of Obstetrics and Gynecology, University of Wisconsin, School of Medicine and Public Health, Madison, WI, USA

    Makeba Williams

  3. Department of Family Medicine and Community Health, University of Wisconsin, School of Medicine and Public Health, Madison, WI, USA

    Sarina Schrager

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Haine, J.E., LoConte, N.K., Tevaarwerk, A.J. (2021). Cancer Survivorship in Women 65 Years and Older. In: Brown, H.W., Williams, M., Schrager, S. (eds) Challenges in Older Women’s Health. Springer, Cham. https://doi.org/10.1007/978-3-030-59058-1_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-59058-1_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-59057-4

  • Online ISBN: 978-3-030-59058-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation